OpenURL Connection Search

Select item for more details and to access through your institution.

Predictors of sinus rhythm 6 weeks after cardioversion of atrial fibrillation: a pre-planned post hoc analysis of the X-VeRT trial.
Published in:
2021
By:
- Cappato, Riccardo;
- Ezekowitz, Michael D;
- Hohnloser, Stefan H;
- Meng, Isabelle Ling;
- Wosnitza, Melanie;
- Investigators, the X-VeRT Steering Committee and;
- Camm, Arthur John;
- Camm, And Arthur John;
- X-VeRT Steering Committee and Investigators
Publication type:
journal article
Patient-reported treatment satisfaction and budget impact with rivaroxaban vs. standard therapy in elective cardioversion of atrial fibrillation: a post hoc analysis of the X-VeRT trial.
Published in:
2016
By:
- Hohnloser, Stefan H.;
- Cappato, Riccardo;
- Ezekowitz, Michael D.;
- Evers, Thomas;
- Sahin, Kurtulus;
- Kirchhof, Paulus;
- Meng, Isabelle Ling;
- van Eickels, Martin;
- Camm, A. John;
- X-VeRT Steering Committee and Investigators
Publication type:
journal article
Rivaroxaban for the treatment of symptomatic deep-vein thrombosis and pulmonary embolism in Chinese patients: a subgroup analysis of the EINSTEIN DVT and PE studies.
Published in:
Thrombosis Journal, 2013, v. 11, n. 1, p. 25, doi. 10.1186/1477-9560-11-25
By:
- Yuqi Wang;
- Chen Wang;
- Zhong Chen;
- Jiwei Zhang;
- Zhihong Liu;
- Bi Jin;
- Kejing Ying;
- Changwei Liu;
- Yuxia Shao;
- Zhicheng Jing;
- Ling Meng, Isabelle;
- Prins, Martin H.;
- Pap, Ákos F.;
- Müller, Katharina;
- Lensing, Anthonie W. A.
Publication type:
Article
Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation.
Published in:
European Heart Journal, 2014, v. 35, n. 47, p. 3346, doi. 10.1093/eurheartj/ehu367
By:
- Cappato, Riccardo;
- Ezekowitz, Michael D.;
- Klein, Allan L.;
- Camm, A. John;
- Ma, Chang-Sheng;
- Le Heuzey, Jean-Yves;
- Talajic, Mario;
- Scanavacca, Maurício;
- Vardas, Panos E.;
- Kirchhof, Paulus;
- Hemmrich, Melanie;
- Lanius, Vivian;
- Meng, Isabelle Ling;
- Wildgoose, Peter;
- van Eickels, Martin;
- Hohnloser, Stefan H.
Publication type:
Article

Found: 4

Predictors of sinus rhythm 6 weeks after cardioversion of atrial fibrillation: a pre-planned post hoc analysis of the X-VeRT trial.

Patient-reported treatment satisfaction and budget impact with rivaroxaban vs. standard therapy in elective cardioversion of atrial fibrillation: a post hoc analysis of the X-VeRT trial.

Rivaroxaban for the treatment of symptomatic deep-vein thrombosis and pulmonary embolism in Chinese patients: a subgroup analysis of the EINSTEIN DVT and PE studies.

Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation.